chemokine (C-C motif) receptor 5 |
BUPIVACAINE HYDROCHLORIDE |
Chemokine CCR5 |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 |
BUPIVACAINE HYDROCHLORIDE |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VII, alpha |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
amiloride-sensitive cation channel 5, intestinal |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VIII, alpha polypeptide |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type XI, alpha |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, beta |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 10, alpha polypeptide |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, alpha polypeptide |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type V, alpha polypeptide |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, beta |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 gamma |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 beta |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 1 |
CADMIUM CHLORIDE |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 7 |
CADMIUM CHLORIDE |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X-like 1, orphan receptor |
CADMIUM CHLORIDE |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
CADMIUM CHLORIDE |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 1 |
CADMIUM CHLORIDE |
Adrenergic beta1 |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic, beta-1-, receptor |
CADMIUM CHLORIDE |
Adrenergic beta1 |
-20% |
NoneNone |
NoneNone |
View
|
arachidonate 15-lipoxygenase, second type |
PHENYLBUTAZONE |
Lipoxygenase 15-LO |
-20% |
NoneNone |
NoneNone |
View
|
arachidonate 15-lipoxygenase |
PHENYLBUTAZONE |
Lipoxygenase 15-LO |
-20% |
NoneNone |
NoneNone |
View
|
arachidonate 15-lipoxygenase |
PHENYLBUTAZONE |
Lipoxygenase 15-LO |
-20% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 4 |
PHENYLHYDRAZINE |
Chemokine CCR4 |
-20% |
NoneNone |
NoneNone |
View
|
progesterone receptor |
LEVOSULPIRIDE |
Progesterone |
-20% |
NoneNone |
NoneNone |
View
|
progesterone receptor |
LEVOSULPIRIDE |
Progesterone |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
PHENYLHYDRAZINE |
Serotonin 5-HT2C |
-20% |
NoneNone |
NoneNone |
View
|
opioid receptor, delta 1 |
PHENYLHYDRAZINE |
Opiate delta |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 |
PRAMOXINE |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
PRAMOXINE |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
tachykinin receptor 1 |
SULFAPHENAZOLE |
Tachykinin NK1 |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 1 |
AMPRENAVIR |
Adrenergic beta1 |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic, beta-1-, receptor |
AMPRENAVIR |
Adrenergic beta1 |
-20% |
NoneNone |
NoneNone |
View
|
DNA encoding receptor of vasoactive intestinal polypeptide |
AMPRENAVIR |
Vasoactive Intestinal Peptide VIP1 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
EBASTINE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
PROPYLTHIOURACIL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
PROPYLTHIOURACIL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
PROPYLTHIOURACIL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 |
LEVOCARNITINE |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
LEVOCARNITINE |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
FMS-like tyrosine kinase 1 |
PROPYLTHIOURACIL |
Vascular Endothelinal Growth Factor (VEGF) |
-20% |
NoneNone |
NoneNone |
View
|
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
PROPYLTHIOURACIL |
Vascular Endothelinal Growth Factor (VEGF) |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
MITOTANE |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 1 |
MITOTANE |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, pi |
MITOTANE |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
AT hook, DNA binding motif, containing 1 (DBSS) |
MITOTANE |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, theta |
MITOTANE |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 2 |
MITOTANE |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
MITOTANE |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
MITOTANE |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 2 |
MITOTANE |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
MITOTANE |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
MITOTANE |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
MITOTANE |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, delta |
MITOTANE |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
MITOTANE |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
dopamine receptor 2 |
RISEDRONIC ACID |
Dopamine D2L |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
SULFADIMETHOXINE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
SULFADIMETHOXINE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
DIELDRIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
DIELDRIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
DIELDRIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
DIELDRIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
DIELDRIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
DIELDRIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
DIELDRIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
DIELDRIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
DIELDRIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
DIELDRIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
DIELDRIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
DIELDRIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
DIELDRIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
DIELDRIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
DIELDRIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4A, cAMP specific |
GLICLAZIDE |
Phosphodiesterase PDE4 |
-20% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4C, cAMP-specific |
GLICLAZIDE |
Phosphodiesterase PDE4 |
-20% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4D |
GLICLAZIDE |
Phosphodiesterase PDE4 |
-20% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4B, cAMP specific |
GLICLAZIDE |
Phosphodiesterase PDE4 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 3 |
LEFLUNOMIDE |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 3 |
LEFLUNOMIDE |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
platelet derived growth factor receptor, alpha polypeptide |
FLUCYTOSINE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
platelet-derived growth factor receptor, alpha polypeptide |
FLUCYTOSINE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
platelet derived growth factor receptor, beta polypeptide |
FLUCYTOSINE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
platelet-derived growth factor receptor, beta polypeptide |
FLUCYTOSINE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
platelet-activating factor receptor |
GENTAMICIN |
Platelet Activating Factor (PAF) |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
GLIMEPIRIDE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
GLIMEPIRIDE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3B |
DANOFLOXACIN |
Phosphodiesterase PDE3 |
-20% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3A |
DANOFLOXACIN |
Phosphodiesterase PDE3 |
-20% |
NoneNone |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
GENTAMICIN |
Protein Tyrosine Kinase, Fyn |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 1d (Non-specific probe) |
GERANIOL |
Adrenergic alpha1D |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
CHLORTETRACYCLINE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
CHLORTETRACYCLINE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
FINASTERIDE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
FINASTERIDE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
FLUCYTOSINE |
Adrenergic, Norepinephrine Transporter |
-20% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 5 |
FLUCYTOSINE |
Chemokine CCR5 |
-20% |
NoneNone |
NoneNone |
View
|
epidermal growth factor receptor |
GENTAMICIN |
Protein Tyrosine Kinase, EGF Receptor |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
VENLAFAXINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
VENLAFAXINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
VENLAFAXINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
VENLAFAXINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
VENLAFAXINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
VENLAFAXINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
VENLAFAXINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
VENLAFAXINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
VENLAFAXINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
VENLAFAXINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
VENLAFAXINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
VENLAFAXINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
VENLAFAXINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
VENLAFAXINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
VENLAFAXINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
VENLAFAXINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
VENLAFAXINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
VENLAFAXINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
VENLAFAXINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
VENLAFAXINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, beta |
CHLORTETRACYCLINE |
Chemokine CXCR2 (IL-8B) |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
CLONAZEPAM |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
CLONAZEPAM |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
opioid receptor, delta 1 |
FINASTERIDE |
Opiate delta |
-20% |
NoneNone |
NoneNone |
View
|
progesterone receptor |
ESMOLOL |
Progesterone |
-20% |
NoneNone |
NoneNone |
View
|
progesterone receptor |
ESMOLOL |
Progesterone |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
LEVOBUPIVACAINE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
LEVOBUPIVACAINE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 3 |
LEVOBUPIVACAINE |
Glycine, Strychnine-Sensitive |
-20% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 1 subunit |
LEVOBUPIVACAINE |
Glycine, Strychnine-Sensitive |
-20% |
NoneNone |
NoneNone |
View
|
glycine receptor, beta subunit |
LEVOBUPIVACAINE |
Glycine, Strychnine-Sensitive |
-20% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 2 subunit |
LEVOBUPIVACAINE |
Glycine, Strychnine-Sensitive |
-20% |
NoneNone |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
SULFASALAZINE |
Protein Tyrosine Kinase, Fyn |
-20% |
NoneNone |
NoneNone |
View
|
A3 adenosine receptor |
UBENIMEX |
Adenosine A3 |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
DIPHENHYDRAMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
EBASTINE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
AMPRENAVIR |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
AMPRENAVIR |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
nitric oxide synthase 2A (inducible, hepatocytes) |
PRIMAQUINE |
Nitric Oxide Synthase, Inducible (iNOS) |
-20% |
NoneNone |
NoneNone |
View
|
nitric oxide synthase 2, inducible |
PRIMAQUINE |
Nitric Oxide Synthase, Inducible (iNOS) |
-20% |
NoneNone |
NoneNone |
View
|
DNA encoding receptor of vasoactive intestinal polypeptide |
OXALIPLATIN |
Vasoactive Intestinal Peptide VIP1 |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
OXALIPLATIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
OXALIPLATIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
OXALIPLATIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
OXALIPLATIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
OXALIPLATIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
OXALIPLATIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
OXALIPLATIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
OXALIPLATIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
OXALIPLATIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
OXALIPLATIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
OXALIPLATIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
OXALIPLATIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
OXALIPLATIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
OXALIPLATIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
OXALIPLATIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
OXALIPLATIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
OXALIPLATIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
OXALIPLATIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
OXALIPLATIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
OXALIPLATIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
TROXIPIDE |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
TROXIPIDE |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
ORPHENADRINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
ORPHENADRINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
ORPHENADRINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
ORPHENADRINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
ORPHENADRINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
ORPHENADRINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
ORPHENADRINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
ORPHENADRINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
ORPHENADRINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
ORPHENADRINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
ORPHENADRINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
ORPHENADRINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
ORPHENADRINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
ORPHENADRINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
ORPHENADRINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
ORPHENADRINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
ORPHENADRINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
ORPHENADRINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
ORPHENADRINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
ORPHENADRINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2C19 monooxygenase |
FLUCYTOSINE |
CYP450-2C19 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|